The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions.If you have any queries about the SPCs on our website then please e-mail

Noroclav 250 mg chewable flavoured tablets for cats and dogs

250 mg/tablet Chewable tablet

Norbrook Laboratories (Ireland) LimitedVPA22664/094/002

Main Information

Trade NameNoroclav 250 mg chewable flavoured tablets for cats and dogs
Active SubstancesAmoxicillin
Clavulanic acid
Strength250 mg/tablet
Dosage FormChewable tablet
Licence HolderNorbrook Laboratories (Ireland) Limited
Licence NumberVPA22664/094/002

Group Information

ATC CodeQJ01CR02 amoxicillin and enzyme inhibitor
Therapeutic ClassAntibacterial


Licence Issued22/06/2012
Legal StatusPOM: Prescription Only Medicine as defined in relevant national legislation


Summary of Product CharacteristicsPDF Version
Package LeafletNo document available
Public Assessment ReportPDF Version
« Back